This post was originally published on News-medical.net
You will shortly be re-directed to the publisher's website
Several rare immune disorders are caused by mutations in the patient’s DNA. The University of Surrey and its collaborators found that targeting the mutated pathways with new drugs offers new hope for people suffering from rare conditions such as immunodeficiencies.